Journal of Antimicrobial Chemotherapy (1992) 30, 839-842
© 1992 The British Society for Antimicrobial Chemotherapy
research-article |
Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone
ICI Pharmaceuticals, Bioscience 1, Mereside Alderly Park, Macclesfield, Cheshire SK10 4TG, UK
Received 8 May 1992; returned 10 August 1992; accepted 10 August 1992
Inhibition of nitric oxide synthesis was investigated in a murine model of advanced sepsis in which antibiotic therapy alone did not improve survival. Seven hours after receiving a lethal intraperitoneal challenge with live Escherichia coli, mice were given either NG-monomethyl-L-arginine (L-NMMA) intravenously, imipenem-cilastatin subcutaneously or a combination of both. L-NMMA (3300 mg/kg) or imipenemcilastatin (10 or 50 mg/kg) given alone did not improve survival; co-administration of L-NMMA and either 10 or 50 mg imipenem-cilastatin/kg improved survival significantly. These findings suggest that nitric oxide contributes to the morbidity associated with advanced sepsis and that nitric oxide synthase inhibition may improve the efficacy of conventional antimicrobial treatment of severe infections.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. H. Han, J. H. Kim, H. S. Seo, M. H. Martin, G.-H. Chung, S. M. Michalek, and M. H. Nahm Lipoteichoic Acid-Induced Nitric Oxide Production Depends on the Activation of Platelet-Activating Factor Receptor and Jak2 J. Immunol., January 1, 2006; 176(1): 573 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. ANNING, M. SAIR, C. P. WINLOVE, and T. W. EVANS Abnormal Tissue Oxygenation and Cardiovascular Changes in Endotoxemia Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1710 - 1715. [Abstract] [Full Text] |
||||
![]() |
R. Gallily, A. Yamin, Y. Waksmann, H. Ovadia, J. Weidenfeld, A. Bar-Joseph, A. Biegon, R. Mechoulam, and E. Shohami Protection Against Septic Shock and Suppression of Tumor Necrosis Factor alpha and Nitric Oxide Production by Dexanabinol (HU-211), a Nonpsychotropic Cannabinoid J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 918 - 924. [Abstract] [Full Text] |
||||
![]() |
A. ROSSELET, F. FEIHL, M. MARKERT, A. GNAEGI, C. PERRET, and L. LIAUDET Selective iNOS Inhibition Is Superior to Norepinephrine in the Treatment of Rat Endotoxic Shock Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 162 - 170. [Abstract] [Full Text] |
||||
![]() |
J. P. Cobb and R. L. Danner Nitric Oxide and Septic Shock JAMA, April 17, 1996; 275(15): 1192 - 1196. [Abstract] [PDF] |
||||
![]() |
K. Fukatsu, H. Saito, R. Fukushima, T. Inoue, M.-T. Lin, T. Inaba, and T. Muto Detrimental Effects of a Nitric Oxide Synthase Inhibitor (N-{omega}-Nitro-L-Arginine-Methyl-Ester) in a Murine Sepsis Model Arch Surg, April 1, 1995; 130(4): 410 - 414. [Abstract] [PDF] |
||||
![]() |
J. L. Henderson, R. Statman, J. N. Cunningham, W. Cheng, P. Damiani, A. Siconolfi, and J. H. Horovitz The Effects of Nitric Oxide Inhibition on Regional Hemodynamics During Hyperdynamic Endotoxemia Arch Surg, December 1, 1994; 129(12): 1271 - 1275. [Abstract] [PDF] |
||||




